164 related articles for article (PubMed ID: 34383246)
1. Population diversity of three variants of the SLC47A2 gene (MATE2-K transporter) in Mexican Mestizos and Native Americans.
Favela-Mendoza AF; Fricke-Galindo I; Cuevas-Sánchez WF; Aguilar-Velázquez JA; Martínez-Cortés G; Rangel-Villalobos H
Mol Biol Rep; 2021 Sep; 48(9):6343-6348. PubMed ID: 34383246
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.
Favela-Mendoza AF; Rangel-Villalobos H; Fricke-Galindo I; Ortega-Vázquez A; Martínez-Cortés G; López-López M
Mol Biol Rep; 2018 Dec; 45(6):2525-2533. PubMed ID: 30317428
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic Evaluation of Metformin and Sulphonylurea Response in Mexican Mestizos with Type 2 Diabetes.
Marta M; Sánchez-Pozos K; Jaimes-Santoyo J; Monroy-Escutia J; Rivera-Santiago C; de Los Ángeles Granados-Silvestre M; Ortiz-López MG
Curr Drug Metab; 2020; 21(4):291-300. PubMed ID: 32407269
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.
Raj GM; Mathaiyan J; Wyawahare M; Priyadarshini R
Drug Metab Pers Ther; 2018 Dec; 33(4):175-185. PubMed ID: 30433870
[TBL] [Abstract][Full Text] [Related]
5. Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes.
Phani NM; Vohra M; Kakar A; Adhikari P; Nagri SK; D'Souza SC; Umakanth S; Satyamoorthy K; Rai PS
Pharmacogenomics; 2018 Jul; 19(11):905-911. PubMed ID: 29914345
[TBL] [Abstract][Full Text] [Related]
6. A common 5'-UTR variant in MATE2-K is associated with poor response to metformin.
Choi JH; Yee SW; Ramirez AH; Morrissey KM; Jang GH; Joski PJ; Mefford JA; Hesselson SE; Schlessinger A; Jenkins G; Castro RA; Johns SJ; Stryke D; Sali A; Ferrin TE; Witte JS; Kwok PY; Roden DM; Wilke RA; McCarty CA; Davis RL; Giacomini KM
Clin Pharmacol Ther; 2011 Nov; 90(5):674-84. PubMed ID: 21956618
[TBL] [Abstract][Full Text] [Related]
7. Association of
Chen P; Cao Y; Chen S; Liu Z; Chen S; Guo Y
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289808
[TBL] [Abstract][Full Text] [Related]
8. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.
Pérez-Gómez N; Fernández-Ortega MD; Elizari-Roncal M; Santos-Mazo E; la Maza-Pereg L; Calvo S; Alcaraz R; Sanz-Solas A; Vinuesa R; Saiz-Rodríguez M
Pharmacogenomics; 2023 Aug; 24(12):651-663. PubMed ID: 37610884
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics.
Chung JY; Cho SK; Kim TH; Kim KH; Jang GH; Kim CO; Park EM; Cho JY; Jang IJ; Choi JH
Pharmacogenet Genomics; 2013 Jul; 23(7):365-73. PubMed ID: 23652408
[TBL] [Abstract][Full Text] [Related]
10. Genetic variability of five ADRB2 polymorphisms among Mexican Amerindian ethnicities and the Mestizo population.
Salas-Martínez MG; Saldaña-Alvarez Y; Cordova EJ; Mendiola-Soto DK; Cid-Soto MA; Luckie-Duque A; Vicenteño-Ayala H; Barajas-Olmos F; Contreras-Cubas C; García-Ortiz H; Jiménez-Ruíz JL; Centeno-Cruz F; Martínez-Hernández A; Mendoza-Caamal EC; Mirzaeicheshmeh E; Orozco L
PLoS One; 2019; 14(12):e0225030. PubMed ID: 31790415
[TBL] [Abstract][Full Text] [Related]
11. Effects of SLC22A2 (rs201919874) and SLC47A2 (rs138244461) genetic variants on Metformin Pharmacokinetics in Pakistani T2DM patients.
Moeez S; Khalid Z; Jalil F; Irfan M; Ismail M; Arif MA; Niazi R; Khalid S
J Pak Med Assoc; 2019 Feb; 69(2):155-163. PubMed ID: 30804576
[TBL] [Abstract][Full Text] [Related]
12. Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.
Salazar-Flores J; Torres-Reyes LA; Martínez-Cortés G; Rubi-Castellanos R; Sosa-Macías M; Muñoz-Valle JF; González-González C; Ramírez A; Román R; Méndez JL; Barrera A; Torres A; Medina R; Rangel-Villalobos H
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1098-104. PubMed ID: 22913530
[TBL] [Abstract][Full Text] [Related]
13. The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.
Stocker SL; Morrissey KM; Yee SW; Castro RA; Xu L; Dahlin A; Ramirez AH; Roden DM; Wilke RA; McCarty CA; Davis RL; Brett CM; Giacomini KM
Clin Pharmacol Ther; 2013 Feb; 93(2):186-94. PubMed ID: 23267855
[TBL] [Abstract][Full Text] [Related]
14. The L125F MATE1 variant enriched in populations of Amerindian origin is associated with increased plasma levels of metformin and lactate.
Morales-Rivera MI; Alemón-Medina R; Martínez-Hernández A; Gómez-Garduño J; Mirzaeicheshmeh E; Altamirano-Bustamante NF; Ilizaliturri-Flores I; Mendoza-Caamal EC; Pérez-Guillé MG; García-Álvarez R; Contreras-Cubas C; Centeno-Cruz F; Revilla-Monsalve C; García-Ortiz H; Barajas-Olmos F; Orozco L
Biomed Pharmacother; 2021 Oct; 142():112009. PubMed ID: 34388523
[TBL] [Abstract][Full Text] [Related]
15. Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.
Dujic T; Zhou K; Yee SW; van Leeuwen N; de Keyser CE; Javorský M; Goswami S; Zaharenko L; Hougaard Christensen MM; Out M; Tavendale R; Kubo M; Hedderson MM; van der Heijden AA; Klimčáková L; Pirags V; Kooy A; Brøsen K; Klovins J; Semiz S; Tkáč I; Stricker BH; Palmer C; 't Hart LM; Giacomini KM; Pearson ER
Clin Pharmacol Ther; 2017 Jun; 101(6):763-772. PubMed ID: 27859023
[TBL] [Abstract][Full Text] [Related]
16. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico.
Nuño-Arana I; Sahagún-Núñez Vdel R; Muñoz-Valle JF; Sandoval L; Pinto-Escalante D; Páez-Riberos LA; Lazalde B; Maldonado-González M; Rangel-Villalobos H
Am J Hum Biol; 2012; 24(4):569-72. PubMed ID: 22434650
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of multidrug and toxin extrusion proteins (MATE1 and MATE2) in South Indian population.
Raj GM; Mathaiyan J; Wyawahare M; Rao KS; Priyadarshini R
Bioimpacts; 2017; 7(1):25-30. PubMed ID: 28546950
[No Abstract] [Full Text] [Related]
18. Forensic parameters for 15 STRs in eight Amerindian populations from the north and west of Mexico.
Rangel-Villalobos H; Martínez-Sevilla VM; Salazar-Flores J; Martínez-Cortez G; Muñoz-Valle JF; Galaviz-Hernández C; Lazalde-Ramos BP; Sosa-Macías M
Forensic Sci Int Genet; 2013 May; 7(3):e62-5. PubMed ID: 23473913
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR4 allele frequencies on Indian and Mestizo population from Mexico.
Vargas-Alarcón G; Gamboa R; Zuñiga J; Hernández-Pacheco G; Ramos-Kuri M; Castillo E; Gómez-Casado E; Martínez-Laso J; Arnaiz-Villena A; Granados J
Hum Immunol; 2000 Mar; 61(3):341-4. PubMed ID: 10689126
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation among four Mexican populations (Huichol, Purepecha, Tarahumara, and Mestizo) revealed by two VNTRs and four STRs.
Rangel-Villalobos H; Rivas F; Sandoval L; Ibarra B; Garcìa-Carvajal ZY; Cantú JM; Figuera LE
Hum Biol; 2000 Dec; 72(6):983-95. PubMed ID: 11236868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
